News | March 07, 2023
Sun Pharma completes acquisition of Concert Pharmaceuticals
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Clinical studies are expected to start in Q2 2023.
This artificial RNA ligase has higher thermostability than natural RNA ligase
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Subscribe To Our Newsletter & Stay Updated
